Amsterdam UMC proudly presents new spin-off Kling BioTherapeutics
November 18, 2021Kling BioTherapeutics is a newly-formed Amsterdam UMC spin-off that is discovering and developing innovative antibody and antibody-derived drugs to treat cancer and infectious disease patients. With its lead program preparing to enter human clinical trials, Kling is well positioned to become an immuno-oncology biotech leader with a
novel discovery platform and a robust pipeline of first in class oncology antibodies. Amsterdam UMC has partnered with U.S.-based venture capital firm Time BioVentures to build Kling, and is excited by the company’s rapid progress in attracting a world-class management team of seasoned drug development executives with impressive track records bringing breakthrough products to patients. The company’s offices and labs are located on Amsterdam UMC’s Meibergdreef campus.
More news
Start-up VU-AMS has big plans with clever stress monitoring device
VU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
News
PULSE Sport Wins Prestigious Dutch Sports Innovation Award 2024
PULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
News
Biotech boost(er) for life sciences innovations
Amsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
News